Beacon Therapeutics has completed the enrolment in its randomised, registrational Phase II/III VISTA trial of laru-zova (laruparetigene zovaparvovec) as a potential treatment for X-linked retinitis ...
LONDON and CAMBRIDGE, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a ...
Please provide your email address to receive an email when new articles are posted on . Laru-zova demonstrated a positive safety profile and early efficacy in improving low luminance visual acuity in ...
Beacon Therapeutics reports promising 6-month data on laru-zova, showing visual function improvements in XLRP patients from the DAWN trial. Beacon Therapeutics announced promising interim results from ...
Anya Zova — real name Anna Bogomazova — signed a developmental contract with WWE in August 2012. The Soviet Union-born actress and comedian was let go by the Stamford-based promotion the following ...
WWE's developmental system went through some major changes in 2012 when FCW transitioned into "NXT." The rebranding brought about a number of changes such as new titles, a move from Tampa to Orlando, ...
It's no secret that models like Natalie Roser work hard for their bodies. But for those of you wondering just how the leading Australian model gets those chiselled abs, then wonder no more. Leading ...
LONDON and CAMBRIDGE, Mass., Dec. 6, 2024 /PRNewswire/ -- Beacon Therapeutics Holdings Limited ('Beacon Therapeutics' or 'the Company'), a leading ophthalmic gene therapy company with a purpose to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results